Navigation Links
Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
Date:2/25/2011

ngs." There may be additional risks that Auxilium does not presently know or that Auxilium currently believes are immaterial which could also cause actual results to differ from those contained in the forward-looking statements. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements.

In addition, forward-looking statements provide Auxilium's expectations, plans or forecasts of future events and views as of the date of this release. Auxilium anticipates that subsequent events and developments will cause Auxilium's assessments to change. However, while Auxilium may elect to update these forward-looking statements at some point in the future, Auxilium specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Auxilium's assessments as of any date subsequent to the date of this release.For More Information, Contact:James E. Fickenscher / CFO

William Q. Sargent, Jr. / V.P., IRAuxilium Pharmaceuticals, Inc.

Auxilium Pharmaceuticals, Inc.(484) 321-5900

(484) 321-5900jfickenscher@auxilium.com

wsargent@auxilium.com
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
4. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
5. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
6. Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
7. Auxilium Pharmaceuticals Reports Preliminary Fourth Quarter 2010 Net Revenue and Announces 2011 XIAFLEX Revenue Guidance
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Israel Brain Technologies (IBT) has ... Israel,s 1 st International Brain Technology ... th in Tel Aviv , recently ... the world by the Wall Street Journal and ... 2013 will showcase the latest breakthroughs in neuroscience and brain ...
(Date:5/23/2013)... MATEO, Calif. , May 23, 2013 /PRNewswire/ ... the company to enable data discovery on their ... users the self-service tools they need to quickly ... meaningful decisions. A Fortune 19 company, ... healthcare services companies. It provides pharmaceuticals and medical ...
(Date:5/23/2013)... 23, 2013  Intercept Pharmaceuticals, Inc. (Nasdaq: ... on the development and commercialization of novel bile acid ... biliary cirrhosis, today announced that Mark Pruzanski ... present at the Deutsche Bank Securities 38th Annual Health ... Wednesday, May 29, 2013 at 4:10 p.m. ET. ...
Breaking Medicine Technology:Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3Cardinal Health Selects Datameer for Healthcare Data Discovery 2
(Date:5/23/2013)... with cancers of the throat and vocal cord ... antacids, but not prescription medications, had a protective ... Epidemiology, Biomarkers & Prevention , a journal of ... studies examining gastric reflux and cancers of the ... Scott M. Langevin, Ph.D., postdoctoral research fellow at ...
(Date:5/23/2013)... San Diego, CA (PRWEB) May 23, 2013 ... Pro Medicus Ltd. (ASX: PME), announced today that ... 1.3.0, available on the Apple App Store*. When used ... Imaging Platform, Visage Ease provides authorized healthcare providers simple ... iPod Touch iOS devices. , In addition to numerous ...
(Date:5/23/2013)... DC (PRWEB) May 23, 2013 Teen birth ... 2011, according to new data released today by ... time, the teen birth rate dropped at least 15% in ... , There were also dramatic declines among all racial/ethnic ... ,     Birth rates declined 40% or more for Hispanic ...
(Date:5/23/2013)... To better serve the architecture and ... to announce the release of its new selections ... division products. Provided by Koroseal, a leader in ... and colors represent a sophisticated response to contemporary ... team of Koroseal experts, Modernfold reviewed hundreds of ...
(Date:5/23/2013)... an important human pathogen that can cause rapidly progressing, ... Jennings said., "Until now we have not known how ... a long-standing mystery how it attaches to the airway ... and not get any symptoms, while some people progress ... to know the detail of how the bacterium colonises ...
Breaking Medicine News(10 mins):Health News:Frequent heartburn may predict cancers of the throat and vocal cord 2Health News:Mobile Imaging Access Leaps Ahead with Visage Ease 2Health News:Mobile Imaging Access Leaps Ahead with Visage Ease 3Health News:Modernfold Debuts New Colors and Patterns for Space Division Products 2Health News:New discovery in fight against deadly meningococcal disease 2
... of another milestone, her 60th birthday, when she received news ... disorder of the bones, leading to thinning of the bones ... ,According to Steve Goldstein, a professor of obstetrics and gynecology ... when we are young is faster than bone loss. But ...
... According to Libyan officials the five Bulgarian nurses and a ... HIV will face a new trial next month.// , ,The ... Libya would begin on 11 May. ,The retrial ... death sentences for the medics who say they were tortured ...
... Gen. Nadeem Ahmed, deputy chairman, Earthquake Rehabilitation and ... that would enable Pakistan recover from the devastating ... be completed within a year, covering some reconstruction ... distribution system, water and sanitation system, skill training, ...
... announced the National Bowel Cancer Screening Programme, which will cover ... of Gastroenterology has unanimously welcomed the introduction of this program. ... later than expected, it is now official that funds are ... Tony Morris, who is the President of the Society as ...
... he was forced to take dramatic action in order to ensure ... says the local DHB began trying to get his wife's anti-nausea ... unless provided with the drug. ,Joanne Piper says that ... The Hawke's Bay hospital refused to provide enough of the drug ...
... Journal of Neurology, Neurosurgery and Psychiatry highlights a case where ... being exposed to high levels of aluminum courtesy the tap ... in 2004. ,Chris Exley, of Keele University, published the ... to the 20 tonnes of aluminum sulphate, which was accidentally ...
Cached Medicine News:Health News:Make No Bones About It: Actress Sally, Fields Osteoporosis Like A star! 2Health News:Exposure To High Aluminum Levels In Tap Water Lead To Rare Form Of Alzheimers 2
Straight 8 mm downcutting Royce blade. Can be placed in closed handle for protection. Rigid handle when folded and locked. Straight 8 mm downcutting blades. Handle length folded 109 mm, 4.3 inches....
Duckbill. 3.5 mm tip. Light curve....
2 mm. Angled 13 degrees, 15 mm from angle to tip. Round handle....
2 mm curved tip. Round handle. Designated most popular model or size....
Medicine Products: